| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
University of Zurich |
| Information provided by: | University of Zurich |
| ClinicalTrials.gov Identifier: | NCT00551057 |
Purpose
The purpose of this trial is to investigate the expression of different inflammatory proteins in cancer and normal pancreatic tissue.
| Condition | Intervention |
|
Pancreatic Neoplasms |
Behavioral: Expression type |
| MedlinePlus related topics: | Cancer Pancreatic Cancer |
| Study Type: | Observational |
| Study Design: | Cohort, Prospective |
| Official Title: | Expression of Inflammatory Proteins in Pancreatic Cancer |
To investigate the expression of different inflammatory proteins in cancer and normal pancreatic tissue
| Estimated Enrollment: | 150 |
| Study Start Date: | October 2007 |
| Estimated Study Completion Date: | October 2012 |
Purpose: to investigate the expression of different inflammatory proteins in cancer and normal pancreatic tissue
Eligibility
| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Patients with pancreatic cancer or chronic pancreatitis
Inclusion criteria:
Exclusion criteria:
Contacts and Locations| Contact: Marc Schiesser, MD | +41 (0)44 255 11 11 | marc.schiesser@usz.ch |
| Switzerland | |||||
| University Hospital Zurich Department of Surgery | Recruiting | ||||
| Zurich, Switzerland | |||||
| Contact: Marc Schiesser marc.schiesser@usz.ch | |||||
| University of Zurich |
| Principal Investigator: | Marc Schiesser, MD | UniversitaetsSpital Zuerich |
More Information
| Study ID Numbers: | 13-2007 |
| First Received: | October 29, 2007 |
| Last Updated: | October 29, 2007 |
| ClinicalTrials.gov Identifier: | NCT00551057 |
| Health Authority: | Switzerland: Swissmedic |
|
|
|
|
